ProCE Banner Activity

The Latest in Stroke Risk Reduction Strategies: Are Your Patients Protected?

Slideset

In these unlocked downloadable slides, expert faculty review the latest data on reducing the risk of stroke in patients with T2D, including data with GLP-1 receptor agonists and SGLT2 inhibitors.

Released: September 27, 2024

Expiration: September 26, 2025

Share

Faculty

Richard E. Pratley

Richard E. Pratley, MD

AdventHealth Samuel E. Crockett Chair in Diabetes Research
Medical Director, Advent Health Diabetes Institute
Senior Investigator and Diabetes Program Lead
AdventHealth Translational Research Institute
Adjunct Professor of Medicine
Johns Hopkins School of Medicine
Orlando, Florida

Alejandro A. Rabinstein

Alejandro A. Rabinstein, MD, FAHA

Professor of Neurology
Chair, Hospital Neurology and Neurocritical Care Division
Mayo Clinic
Rochester, Minnesota

Jay H. Shubrook

Jay H. Shubrook, DO, FACOFP, FAAFP

Professor and Diabetologist
Department of Clinical Sciences and Community Health
Touro University California
College of Osteopathic Medicine
Vallejo, California

Provided by

Provided by Clinical Care Options, LLC.

ProCE Banner

Supporters

Supported by an educational grant from Novo Nordisk.

Novo Nordisk